Phase
Condition
Genitourinary Prolapse
Treatment
Transvaginal mesh for anterior pelvic organ prolapse repair
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria Non-fertile women > 18 years1 2. Symtomatic anterior prolapse with or without apical vaginal wall involvement according POP-Q score ≥ 2. (Corresponding to Aa, Ba ≥ -1 and where applicable C ≥ -1/2 TVL ).
Subjects with recurrent prolapse or complex primary prolapse are eligible for the study.
Scheduled mesh-augmented anterior POP repair with Calistar S 5. Signed inform consent
Exclusion criteria
Fertile women
Patients with active or latent infection of the vagina, cervix or uterus
Patients with previous or current vaginal, cervical or uterine cancer
Previous, current or planned pelvic radiation therapy
Known allergy to polypropylene
Subject is unable or unwilling to complete questionnaires (either self-administered, assisted or interviewed) and/or to follow scheduled visits and/or to sign informed consent
Study Design
Study Description
Connect with a study center
Helios Hospital Erfurt, Department of gynaecology
Erfurt, Thüringen
GermanySite Not Available
St. Hedwig Hospital
Berlin,
GermanySite Not Available
Evangelic Diakonie Hospital
Freiburg,
GermanySite Not Available
St. Elisabeth-Hospital Leipzig
Leipzig,
GermanySite Not Available
Hospital Tettnang
Tettnang,
GermanySite Not Available
University Hospital Tübingen
Tübingen,
GermanySite Not Available
AMC Amsterdam
Amsterdam,
NetherlandsSite Not Available
St. Antonius Ziekenhuis
Nieuwegein,
NetherlandsSite Not Available


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.